{"id":"1e7a2927-4dcb-5fff-bf43-0d6acb73e744","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-potency-is-structural-not-greasy","predicate":"binds","statement":"The GABA-A receptor and hypnotic potencies of etomidate and the etomidate analogs ranged by 91-fold and 53-fold respectively, these potency measurements were significantly correlated with r = 0.72, but neither measurement correlated with drug hydrophobicity with r = 0.019 and 0.005 respectively, statistically significant and predictive comparative molecular field analysis models were generated, and a pharmacophore model was built revealing both the structural elements associated with high potency and the interactions that these elements make with the etomidate-binding site.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"1ad52921-9403-592b-9a5a-32033aff9d56","mechanism_event_label":"How well these anaesthetics work tracks their exact shape at a binding site and not at all how greasy they are.","subject":{"id":"e3ffbb81-73b5-58b4-9885-07b9c9f4af34","slug":"etomidate-binding-site","display_name":"The etomidate-binding site of the GABA-A receptor","entity_type_key":"protein_state"},"object":{"id":"c404093f-68d4-555d-bf06-d13d711e6ff0","slug":"etomidate","display_name":"Etomidate","entity_type_key":"drug"},"evidence_count":1,"mechanism_event":{"id":"1ad52921-9403-592b-9a5a-32033aff9d56","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-potency-is-structural-not-greasy-event","event_type":"biochemical_relationship","label":"How well these anaesthetics work tracks their exact shape at a binding site and not at all how greasy they are.","description":"The GABA-A receptor and hypnotic potencies of etomidate and the etomidate analogs ranged by 91-fold and 53-fold respectively, these potency measurements were significantly correlated with r = 0.72, but neither measurement correlated with drug hydrophobicity with r = 0.019 and 0.005 respectively, statistically significant and predictive comparative molecular field analysis models were generated, and a pharmacophore model was built revealing both the structural elements associated with high potency and the interactions that these elements make with the etomidate-binding site.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"42c736ff-8255-5d52-9e75-e6279297bb46","slug":"anaesthetic-hydrophobicity","display_name":"Hydrophobicity of an anaesthetic agent","entity_type_key":"cellular_process"},"role":"noncorrelated_property","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"85471697-fdf9-5d67-a937-d00e6eb7cc93","slug":"loss-of-righting-reflex","display_name":"Loss of the righting reflex","entity_type_key":"cellular_process"},"role":"animal_endpoint","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5e42971b-427f-5b32-968b-870b347135ab","slug":"gaba-a-receptors","display_name":"GABA-A receptor anion channels","entity_type_key":"protein_family"},"role":"target_receptor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"e3ffbb81-73b5-58b4-9885-07b9c9f4af34","slug":"etomidate-binding-site","display_name":"The etomidate-binding site of the GABA-A receptor","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"c404093f-68d4-555d-bf06-d13d711e6ff0","slug":"etomidate","display_name":"Etomidate","entity_type_key":"drug"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/gaba-research/26691905.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1143ce4efd922ff301b6a1ca54f0a84b8ffe08bf53946b8fcee1f3ad17a8b7eb\", \"start_char\": 0, \"end_char\": 1844, \"text_sha256\": \"1143ce4efd922ff301b6a1ca54f0a84b8ffe08bf53946b8fcee1f3ad17a8b7eb\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Voltage clamp electrophysiology of a sensitising channel mutant with a loss of righting reflex assay and comparative molecular field analysis","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"A series of etomidate analogs spanning a 91-fold range of receptor potency","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Recombinant receptors carrying a mutation that enhances anaesthetic sensitivity, paired with an animal endpoint. The correlation is across analogs rather than within one drug.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.","comparator":null,"unit":null,"notes":"","entity":{"slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Rat and recombinant receptor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"How well these anaesthetics work tracks their exact shape at a binding site and not at all how greasy they are.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[gb-p26691905] γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs. (2016). https://pubmed.ncbi.nlm.nih.gov/26691905/ DOI: 10.1097/aln.0000000000000992","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Recombinant alpha1beta3gamma2 receptors and whole animals","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"d2a07960-394b-5263-b7ad-5a31b3b97b47","evidence_kind":"source_excerpt","locator":"Lines 248-259","start_line":248,"end_line":259,"excerpt":"### gb-potency-is-structural-not-greasy\nThe GABA-A receptor and hypnotic potencies of etomidate and the etomidate analogs ranged by 91-fold and 53-fold respectively, these potency measurements were significantly correlated with r = 0.72, but neither measurement correlated with drug hydrophobicity with r = 0.019 and 0.005 respectively, statistically significant and predictive comparative molecular field analysis models were generated, and a pharmacophore model was built revealing both the structural elements associated with high potency and the interactions that these elements make with the etomidate-binding site.\nCondition category: normal\nnutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.\nplain_language: How well these anaesthetics work tracks their exact shape at a binding site and not at all how greasy they are.\norganism: Rat and recombinant receptor\ntissue_or_cell_type: Recombinant alpha1beta3gamma2 receptors and whole animals\nexperimental_model: Voltage clamp electrophysiology of a sensitising channel mutant with a loss of righting reflex assay and comparative molecular field analysis\nlimitations: Recombinant receptors carrying a mutation that enhances anaesthetic sensitivity, paired with an animal endpoint. The correlation is across analogs rather than within one drug.\nexposure: A series of etomidate analogs spanning a 91-fold range of receptor potency\nevidence_span: {\"source_cache\": \"artifacts/gaba-research/26691905.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1143ce4efd922ff301b6a1ca54f0a84b8ffe08bf53946b8fcee1f3ad17a8b7eb\", \"start_char\": 0, \"end_char\": 1844, \"text_sha256\": \"1143ce4efd922ff301b6a1ca54f0a84b8ffe08bf53946b8fcee1f3ad17a8b7eb\"}\n[gb-p26691905] γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs. (2016). https://pubmed.ncbi.nlm.nih.gov/26691905/ DOI: 10.1097/aln.0000000000000992","model_system":"Voltage clamp electrophysiology of a sensitising channel mutant with a loss of righting reflex assay and comparative molecular field analysis","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [gb-p26691905] γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs. (2016). https://pubmed.ncbi.nlm.nih.gov/26691905/ DOI: 10.1097/aln.0000000000000992","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"197c25bb-45fa-5e97-b3ab-2d2eff4e0d0a","stable_key":"import-1b599eb7-b22a-5fda-bcf0-9d92b5ae1311","title":"GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"07e36027ff70dbbe5563cddfa4758fd9b9b6eec148faecccafd476900b770456","revision_id":"a12d61de-f189-5bda-af3d-f31a1e61bccf","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}